Top 10 pharma R&D budgets in 2022

Another R&D budget ranking has arrived, and Roche remains the top dog among the world’s largest pharmaceutical companies. Roche spent 14.05 billion Swiss francs on R&D in 2022, or roughly $15.15 billion. That’s about $550 million more than Johnson & Johnson, which retained its silver medal position after jumping ahead of Merck & Co. in 2020.